1. Home
  2. Press release

AIM Vaccine Co., Ltd. Press Release

AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share
Oct 05, 2022 18:55 JST
AIM Vaccine Co., Ltd. ("AIM Vaccine" or the "Company", together with its subsidiaries, the "Group", stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines)
More info..
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK
Sep 23, 2022 17:06 JST
AIM Vaccine Co., Ltd. ("AIM Vaccine"; 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), announced the proposed listing of its H shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today.
More info..
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance
Jan 12, 2022 10:26 JST
On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report on the analysis results of the phase I clinical trial data of its mRNA COVID-19 vaccine (LVRNA009).
More info..

Latest Release


TOYOTA GAZOO Racing Reverting to "GAZOO Racing" to Pass on and Evolve the Making of Ever-better Cars and the Fostering of Talent
Jan 07, 2026 22:04 JST

TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Release "The TANAKA 2025" a Perfume that Expresses the Fragrance of Gold (Au)
Jan 07, 2026 22:00 JST

Toyota's European R&D center changes its name and competes in WEC with a new brand
Jan 07, 2026 21:50 JST

Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries
Jan 07, 2026 12:27 JST

Mitsubishi Motors to Celebrate "Delica Festival" with Custom Versions of Delica D:5 and Delica Mini at Tokyo Auto Salon 2026
Jan 06, 2026 16:25 JST

Mitsubishi Motors Launches the Xforce in Taiwan
Jan 06, 2026 14:42 JST

Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China

Jan 06, 2026 10:43 JST

Alpha Growth plc: Alpha Longevity Management Ltd Expands Global Platform with Launch of Alpha Alternative Global Fund and Strengthening of Executive Leadership Team
Jan 05, 2026 16:00 JST

The Tampere city region chose Fujitsu to deliver and develop the area's ICT services
Jan 05, 2026 15:23 JST

Honda Newly Launches "Discover Honda" Content Curation Media Platform
Dec 26, 2025 17:34 JST

Mazda Selected for A List in CDP Water Security for the First Time
Dec 26, 2025 17:19 JST

Fujitsu Develops Fujitsu Kozuchi Physical AI 1.0 for Seamless Integration of Physical and Agentic AI
Dec 26, 2025 14:04 JST

Establishment of DOCOMO Innovation Fund IV, a Corporate Venture Investment Fund
Dec 26, 2025 13:53 JST

The General Incorporated Association Generative AI Japan Announces the Winners of the Japan Generative AI Award 2025
Dec 26, 2025 11:00 JST

BCQ (01963.HK) to Pay RMB 585 Million Cash Dividend, Driving Share Price and Yield Upside
Dec 25, 2025 18:23 JST

Tohoku University and Fujitsu utilize Causal AI to discover superconductivity mechanism of promising new functional material
Dec 23, 2025 14:58 JST

Toward an Athlete- and Planet-Friendly Hakone Ekiden: All Vehicles Provided for the 2026 Race Will Be Electrified
Dec 23, 2025 03:18 JST

MHI Group to Accelerate Development of Digital Talent
Dec 23, 2025 02:57 JST

MHI and EXEO Group Build and Begin Commercial Use of Japan's First GPU Servers with Two-Phase DLC
Dec 23, 2025 02:20 JST

MHI Participates in Demonstration Testing of Vehicle-Infrastructure Integration System for Autonomous Buses in Shimotsuke City
Dec 19, 2025 03:24 JST
 More Latest Release >>